3 Year Absolute Returns
82.46% ↑
NAV (₹) on 20 Aug 2026
43.37
1 Day NAV Change
0.39%
Risk Level
Very High Risk
Rating
-
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund is a Equity mutual fund categorized under Sector, offered by ICICI Prudential Asset Management Co. Ltd.. Launched on 25 Jun 2018, ... Read more
AUM
₹ 6,802.61 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 83.89% |
| Hospitals & Medical Services | 8.96% |
| Treps/Reverse Repo | 2.57% |
| Insurance Distributor | 1.27% |
| Chemicals - Organic - Others | 1.18% |
| Chemicals - Speciality | 1.12% |
| Medical Equipment & Accessories | 0.75% |
| Current Assets | 0.27% |
| Cash | 0.01% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 12.69% | ₹ 863.50 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 8.45% | ₹ 574.97 | Pharmaceuticals |
| Cipla Ltd. | 6.56% | ₹ 445.96 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 6.03% | ₹ 410.11 | Pharmaceuticals |
| Mankind Pharma Ltd. | 5.47% | ₹ 372.19 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 5.11% | ₹ 347.80 | Pharmaceuticals |
| Biocon Ltd. | 4.97% | ₹ 338.14 | Pharmaceuticals |
| Cohance Lifesciences Ltd. | 3.92% | ₹ 266.37 | Pharmaceuticals |
| Medplus Health Services Ltd | 3.80% | ₹ 258.36 | Pharmaceuticals |
| Syngene International Ltd. | 3.26% | ₹ 221.81 | Pharmaceuticals |
| MAX Healthcare Institute Ltd | 2.81% | ₹ 191.30 | Hospitals & Medical Services |
| Abbott India Ltd. | 2.63% | ₹ 178.92 | Pharmaceuticals |
| TREPS | 2.57% | ₹ 174.93 | Others |
| Alembic Pharmaceuticals Ltd. | 2.43% | ₹ 165.58 | Pharmaceuticals |
| Blue Jet Healthcare Ltd. | 2.39% | ₹ 162.70 | Pharmaceuticals |
| Lupin Ltd. | 2.23% | ₹ 151.41 | Pharmaceuticals |
| Pfizer Ltd. | 1.97% | ₹ 133.86 | Pharmaceuticals |
| Thyrocare Technologies Ltd. | 1.95% | ₹ 132.39 | Hospitals & Medical Services |
| Akums Drugs and Pharmaceuticals Ltd. | 1.89% | ₹ 128.59 | Pharmaceuticals |
| Astrazeneca Pharma India Ltd. | 1.86% | ₹ 126.21 | Pharmaceuticals |
| Entero Healthcare Solutions | 1.72% | ₹ 116.98 | Pharmaceuticals |
| Rainbow Childrens Medicare Ltd | 1.51% | ₹ 102.78 | Hospitals & Medical Services |
| Metropolis Healthcare Ltd. | 1.49% | ₹ 101.43 | Hospitals & Medical Services |
| Alivus Life Sciences Ltd. | 1.33% | ₹ 90.39 | Pharmaceuticals |
| Medi Assist Healthcare Services Ltd | 1.27% | ₹ 86.20 | Insurance Distributor |
| Fine Organic Industries Ltd. | 1.18% | ₹ 80.03 | Chemicals - Organic - Others |
| Hikal Ltd. | 1.18% | ₹ 80.58 | Pharmaceuticals |
| Aarti Drugs Ltd. | 1.16% | ₹ 78.86 | Pharmaceuticals |
| Sanofi Consumer Healthcare India Ltd | 1.12% | ₹ 75.87 | Chemicals - Speciality |
| Aurobindo Pharma Ltd. | 0.81% | ₹ 55.40 | Pharmaceuticals |
| Windlas Biotech Ltd. | 0.75% | ₹ 51.30 | Pharmaceuticals |
| Laxmi Dental Ltd. | 0.75% | ₹ 50.96 | Medical Equipment & Accessories |
| FDC Ltd. | 0.74% | ₹ 50.20 | Pharmaceuticals |
| Manipal Health Enterprises Ltd. | 0.73% | ₹ 49.95 | Hospitals & Medical Services |
| Indoco Remedies Ltd. | 0.54% | ₹ 36.48 | Pharmaceuticals |
| Jupiter Life Line Hospitals Ltd | 0.47% | ₹ 31.67 | Hospitals & Medical Services |
| Net Current Assets | 0.27% | ₹ 18.04 | Others |
| Cash Margin - Derivatives | 0.01% | ₹ 0.41 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 7.40% | 8.13% | 8.43% | 22.19% |
| Category returns | 4.95% | 7.39% | 6.92% | 23.87% |
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹30.49 | 31.40% | 174.92% | 0.00% | ₹10,709 | 1.79% |
Very High
|
What is the current NAV of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth?
What is the fund size (AUM) of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth?
What are the historical returns of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth?
What is the risk level of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth?
What is the minimum investment amount for ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article